All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

20

Reset

20 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BioNTech SE · Influenza, COVID-19, COVID-19 (Coronavirus Disease 2019)

  • ibuzatrelvirPF-07817883Phase 32 trials

    Pfizer · COVID-19 SARS-CoV-2 Infection, COVID-19 Infection

  • IIV-HDstandalonePhase 32 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization

  • RVX000222apabetalone, RVX-208Phase 32 trials

    Resverlogix Corp · Post-Acute COVID-19 Syndrome, Kidney Failure, Chronic

  • VYD2311Phase 32 trials

    Invivyd, Inc. · Long COVID, COVID-19 (SARS-CoV-2 Infection), COVID 19 Vaccine

  • DAS181Phase 31 trial

    Ansun Biopharma, Inc. · Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised

  • MolnupiravirMK-4482, LAGEVRIOPhase 31 trial

    Merck & Co. · Coronavirus Disease (COVID-19)

  • NVXC19EU licensed, standalonePhase 31 trial

    Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization

  • SCTA01Phase 31 trial

    Sinocelltech Ltd. · COVID-19, SARS-CoV-2

  • VYD222pemivibartPhase 31 trial

    Invivyd, Inc. · COVID-19, SARS-CoV-2

  • VYD2311-MDPhase 31 trial

    Invivyd, Inc. · COVID-19

  • VYD2311-SDPhase 31 trial

    Invivyd, Inc. · COVID-19

  • RimonabantPhase 24 trials

    Sinfatin S.L · Chronic Stroke, Subacute Stroke, Post-COVID-19 Syndrome

  • Ever Supreme Bio Technology Co., Ltd. · COVID-19 Infection, Multiple Sclerosis, ST Elevation Myocardial Infarction

  • COH04S1GEO-CM04S1, Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1Phase 22 trials

    GeoVax, Inc. · COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm, Leukemia

  • CVXGACVXGA50, PIV5-SARS CoV-2Phase 22 trials

    CyanVac LLC · COVID-19

  • rC19Novavax's adjuvanted recombinant COVID-19Phase 22 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization

  • AV-001Phase 21 trial

    Vasomune Therapeutics, Inc. · Acute Respiratory Distress Syndrome, Viral or Bacterial Infections, Pneumonia

  • GC4006APhase 21 trial

    GC Biopharma Corp · Covid-19 Prevention

  • RatutrelvirPhase 21 trial

    Traws Pharma, Inc. · COVID - 19

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.